Alyeska Investment Group, L.P. Jazz Pharmaceuticals PLC Transaction History

Alyeska Investment Group, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$140.71 - $165.05 $17.3 Million - $20.3 Million	-123,243 Reduced 96.33%	4,691 $774,000
Q3 2020 Nov 16, 2020	SELL	$105.46 - $144.13 $8.17 Million - $11.2 Million	-77,516 Reduced 37.73%	127,934 $18.2 Million
Q2 2020 Aug 14, 2020	BUY	$95.68 - $121.88 $19.1 Million - $24.3 Million	199,452 Added 3325.31%	205,450 $22.7 Million
Q1 2020 May 15, 2020	BUY	$87.74 - $152.74 $76,684 - $133,494	874 Added 17.06%	5,998 $598,000
Q3 2019 Nov 14, 2019	BUY	$125.18 - $143.24 $641,422 - $733,961	5,124 New	5,124 $656,000

516

57.8M

188K

110K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.54B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.